Home » Healthcare » Europe Biopreservation Market

Europe Biopreservation Market By Type (Natural Preservatives, Microbial Preservatives, Chemical Preservatives); By Application (Food and Beverages, Pharmaceuticals, Cosmetics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Europe Biopreservation Market Size 2023	USD 647.08 million
Europe Biopreservation Market, CAGR	23.95%
Europe Biopreservation Market Size 2032	USD 5,783.90 million

Market Overview

The Europe Biopreservation Market is projected to grow from USD 647.08 million in 2023 to an estimated USD 5,783.90 million by 2032, with a compound annual growth rate (CAGR) of 23.95% from 2024 to 2032. The growth is driven by the increasing demand for biopreservation techniques in sectors such as healthcare, biobanking, and pharmaceuticals, as well as advancements in the preservation of biological samples and tissues.

Several key drivers are fueling this market expansion. The rising demand for cell and tissue-based therapies, along with the growing need for efficient storage and transport of biological materials, is a significant trend. Additionally, the increasing number of clinical trials and the growing adoption of personalized medicine are contributing to market growth. Technological advancements in biopreservation solutions, including improvements in cryopreservation techniques and the use of better cryoprotectants, are also playing a pivotal role in market expansion.

Geographically, Europe holds a significant share of the biopreservation market, with major contributors including the UK, Germany, and France. The region benefits from a robust healthcare infrastructure, increasing investments in biotechnology research, and a strong emphasis on precision medicine. Key players in the market include Thermo Fisher Scientific, BioLife Solutions, and Merck Group, which are at the forefront of providing innovative biopreservation technologies and solutions.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Europe Biopreservation Market is projected to grow from USD 647.08 million in 2023 to USD 5,783.90 million by 2032, with a CAGR of 23.95% from 2024 to 2032.
Key drivers include the rising demand for cell and tissue-based therapies, advancements in cryopreservation technologies, and the growing adoption of personalized medicine and clinical trials.
Innovations in cryopreservation, such as improved cryoprotectants and storage techniques, are pivotal in enhancing biopreservation solutions across various industries.
High costs of advanced preservation technologies and the lack of standardized regulations across regions present challenges to widespread market adoption.
Western Europe leads the market, accounting for 50% of the market share, driven by countries like Germany, the UK, and France with strong biotech and healthcare infrastructure.
Eastern and Southern Europe are seeing growth in demand due to increasing investments in healthcare and biotechnological research.
Prominent players such as Thermo Fisher Scientific, BioLife Solutions, and Merck Group are leading the market, providing advanced biopreservation technologies and solutions.

Market Drivers

Rising Demand for Biobanking and Cell & Tissue-Based Therapies

The growing demand for biobanking and cell & tissue-based therapies is one of the primary drivers of the biopreservation market in Europe. Biobanks store biological materials such as tissues, blood, and DNA samples for research and diagnostic purposes, including clinical trials. These materials require stringent preservation techniques to maintain their integrity for long periods. In Europe, an increase in research activities related to regenerative medicine and stem cell therapies has accelerated the need for advanced biopreservation solutions. For instance, the increasing prevalence of chronic diseases like cancer necessitates extensive research using biological samples stored in biobanks. In the European Union, approximately 1.4 million males and 1.2 million females have been diagnosed with cancer, prompting researchers to utilize human specimens for drug discovery and treatment development.Biopreservation technologies such as cryopreservation and vitrification are essential for the long-term storage of biological samples, helping researchers and clinicians carry out successful studies in personalized medicine and genetic research. Additionally, the rising adoption of cell and tissue-based therapies for treating diseases like cancer, cardiovascular diseases, and neurological disorders has created an imperative for effective preservation solutions to ensure the viability and functionality of these biological samples.

Advancements in Cryopreservation Techniques

Advancements in cryopreservation technologies play a vital role in driving the growth of the biopreservation market. Cryopreservation involves freezing cells, tissues, or other biological materials to subzero temperatures, halting biological activity and preserving them for future use. This technique is crucial for storing a wide range of biological specimens, including sperm, oocytes, embryos, and stem cells. In recent years, significant improvements in cryopreservation methods, such as the development of better cryoprotectants and improved freezing and thawing protocols, have increased the efficiency and reliability of preserving biological samples. Additionally, these advancements enhance the overall effectiveness of biopreservation methods by reducing human error through innovations in storage devices like automated cryogenic systems.Moreover, innovations in storage devices have further enhanced preservation techniques by optimizing sample storage capacity. These advancements contribute to the broader adoption of biopreservation techniques in the pharmaceutical, healthcare, and research industries across Europe.

Increased Focus on Personalized Medicine

Personalized medicine, which tailors treatment based on an individual’s genetic profile, is becoming a significant trend in healthcare. As this field expands, the demand for biopreservation technologies continues to grow, particularly for the storage of biological materials like tissue samples, blood, and DNA. Personalized medicine relies heavily on the analysis of these samples to understand a patient’s genetic makeup and predict how they will respond to specific treatments. The ability to store and preserve these biological materials without compromising their integrity is critical for the success of personalized medicine initiatives. Furthermore, as healthcare increasingly focuses on tailoring treatments to individual genetic profiles, the integration of biobanks into clinical research facilitates access to high-quality specimens necessary for ongoing studies.Advancements in genomics and biotechnology have created new opportunities for researchers to develop targeted therapies, leading to greater investments in biopreservation techniques and biobanks across Europe. As personalized medicine moves toward widespread clinical application, biopreservation technologies will continue to play an essential role in enabling long-term storage and preservation of biological materials for clinical research and patient care.

Growth in Pharmaceutical and Biotech Industry Investments

The growing investments in the pharmaceutical and biotechnology sectors are driving the demand for biopreservation solutions. The rapid advancement of drug development, particularly in biologics and biosimilars, requires robust biopreservation methods to ensure the stability of raw materials, clinical samples, and finished products. Biopreservation is also essential for the storage and transportation of biologic drugs, which often need to be kept at specific temperatures to maintain their efficacy. For instance, substantial investments are being made in research and development (R&D) within these sectors to develop new therapies and improve existing ones—particularly in areas such as immunotherapy, cancer treatment, and gene therapy. These innovations require effective biopreservation solutions to safeguard biological materials and ensure their effectiveness when used in clinical trials or commercialized therapies. Furthermore, the increasing number of clinical trials being conducted in Europe, driven by collaborations between universities, hospitals, and pharmaceutical companies, further contributes to the demand for advanced biopreservation technologies.

Market Trends

Adoption of Advanced Cryopreservation Techniques

One of the most prominent trends in the Europe Biopreservation Market is the growing adoption of advanced cryopreservation techniques. Cryopreservation, the process of freezing biological materials to preserve them for long periods, has been integral to the biopreservation sector, especially for the storage of cells, tissues, and other biological samples. Recent innovations have significantly improved the effectiveness and efficiency of cryopreservation. Notably, the development of new cryoprotectants has minimized the damage caused by ice crystal formation during freezing and thawing processes. Additionally, advancements in controlled-rate freezing devices and automated cryogenic systems have made it possible to store biological materials more precisely and efficiently.For instance, millions of seed samples are securely frozen in the Svalbard Global Seed Vault, emphasizing the critical role of cryopreservation in ensuring food and crop security. Additionally, nearly every biomedical research laboratory maintains frozen stocks of cells to prevent phenotypic drift and to preserve rare or valuable biological materials, such as specific primary and clinical samples. This practice is particularly transformative in fertility treatments, where the ability to store oocytes, spermatozoa, and embryos allows individuals to preserve their fertility for extended periods, especially in cases where it may be compromised due to medical conditions or treatments. Furthermore, cryopreservation has become essential in developing innovative cancer therapies, enabling the successful transportation and storage of patients’ cells for future therapeutic applications. This trend is particularly relevant in industries such as stem cell research, regenerative medicine, and fertility preservation, where the need for high-quality, long-term sample storage is critical. As these technologies continue to improve, they enhance the ability to store a wider range of biological materials with greater viability and usability, thereby expanding their application across healthcare and research domains.

Integration of Biopreservation with Personalized Medicine

The increasing integration of biopreservation techniques with personalized medicine is another key trend shaping the Europe Biopreservation Market. Personalized medicine, which involves tailoring medical treatments to an individual’s unique genetic makeup, heavily relies on biological samples such as blood, tissues, and genetic material. These samples must be stored securely and in optimal conditions to maintain their integrity for genetic testing and therapeutic applications. Biopreservation plays a crucial role in ensuring that these samples remain viable over long periods, especially when patients undergo treatments involving cell therapies or gene therapies. In Europe, where personalized medicine is rapidly gaining traction, there is an increasing need for advanced biopreservation solutions.The growth of precision medicine initiatives—such as genomics-driven drug development, biomarker discovery, and individualized treatment plans—necessitates the use of cutting-edge preservation technologies to ensure that biological samples remain suitable for long-term analysis. This integration of biopreservation and personalized medicine is helping to shape the future of healthcare by providing more accurate, efficient, and tailored treatment options for patients.

Expansion of Biobank Networks Across Europe

The expansion of biobank networks across Europe is another significant trend contributing to the growth of the biopreservation market. Biobanks are facilities that store biological materials, including tissues, blood, and DNA, for use in research, diagnostics, and therapeutic applications. These materials are critical for advancing medical research and clinical trials, particularly in fields such as oncology, rare diseases, and genetic research. In Europe, the establishment and expansion of national and international biobanks are on the rise, with various government-funded initiatives and private partnerships driving their growth.These biobanks require advanced biopreservation technologies to maintain the quality and integrity of their stored samples over time. As the need for large-scale biobanking continues to increase—driven by growing research investments and collaborations between academic institutions and the pharmaceutical industry—biopreservation solutions are playing a key role in supporting the storage, transport, and use of biological materials in clinical and research settings. The development of standardized biobank practices alongside advancements in storage technologies is further fueling the demand for biopreservation services in Europe.

Focus on Sustainable and Cost-Effective Biopreservation Solutions

Sustainability and cost-effectiveness are becoming increasingly important factors in the European biopreservation market. As the market expands, companies are focusing on developing more sustainable biopreservation technologies that can reduce environmental impact while maintaining the efficacy of biological sample preservation. Innovations such as eco-friendly cryopreservation agents, energy-efficient storage solutions, and renewable resources for biological sample storage are gaining traction.This trend is partly driven by growing regulatory pressure to reduce carbon footprints and minimize the use of hazardous materials in healthcare and research industries. Moreover, the cost of biopreservation services and equipment has been a key consideration—particularly as these technologies are adopted across diverse sectors. Companies are therefore focused on creating cost-effective solutions that do not compromise the quality or integrity of stored samples. The increasing demand for efficient and affordable preservation technologies is prompting suppliers to innovate and streamline production processes while also exploring new models for shared or centralized storage—further driving market growth.

Market Challenges

High Cost of Biopreservation Technologies and Equipment

One of the significant challenges in the Europe Biopreservation Market is the high cost associated with biopreservation technologies and equipment. Advanced biopreservation methods, such as cryopreservation, require specialized infrastructure, including cryogenic storage systems, controlled-rate freezers, and temperature monitoring devices. These technologies are capital-intensive, and their installation, maintenance, and operational costs can be prohibitively high for smaller research institutions, biotech startups, and healthcare facilities. Additionally, the need for high-quality cryoprotectants, which are critical for minimizing cellular damage during freezing and thawing, further increases costs. While large pharmaceutical companies and research organizations can absorb these expenses, smaller entities may face financial barriers to adopting state-of-the-art biopreservation solutions. Furthermore, the ongoing need for research and development to improve preservation methods adds to the overall expenditure in the sector. As a result, the high costs associated with biopreservation technologies can limit their widespread adoption, especially in price-sensitive markets or in regions with constrained healthcare budgets.

Regulatory and Standardization Challenges

Another challenge faced by the Europe Biopreservation Market is the lack of standardized regulations and guidelines for biopreservation practices. Although there are regulations in place to ensure the safety and quality of biological samples, there is a lack of uniformity across the region regarding preservation methods, storage protocols, and the use of cryoprotectants. This can lead to discrepancies in the quality of preserved materials, impacting the effectiveness of research and clinical applications. Additionally, the complex regulatory landscape in Europe, with varying requirements in different countries, can hinder the seamless implementation of biopreservation technologies across borders. Regulatory inconsistencies may create delays in the approval of new preservation techniques or storage systems, which can slow down innovation and market growth. Standardizing protocols and regulations across Europe would not only streamline processes but also help improve the overall reliability and efficiency of biopreservation practices, ensuring that biological materials are stored and used safely and consistently across various applications.

Market Opportunities

Growth in Regenerative Medicine and Stem Cell Research

One of the key opportunities in the Europe Biopreservation Market lies in the increasing demand for regenerative medicine and stem cell research. Regenerative medicine, which involves using stem cells to repair or replace damaged tissues and organs, relies heavily on biopreservation techniques to maintain the viability of stem cells, tissues, and biological samples for research and clinical use. As Europe continues to lead in cutting-edge research related to stem cells, gene therapies, and tissue engineering, the need for efficient and reliable biopreservation solutions will expand. This growth in regenerative medicine presents a significant opportunity for biopreservation technology providers to develop innovative storage solutions that ensure the long-term stability of biological materials. With ongoing investments in healthcare innovation and an increasing number of clinical trials in Europe, the demand for advanced preservation techniques in these fields will drive market expansion.

Expansion of Biobanks and Collaborative Research Initiatives

Another lucrative opportunity in the Europe Biopreservation Market is the expansion of biobanks and collaborative research initiatives. Biobanks, which store biological samples for use in medical research, diagnostics, and drug development, are growing rapidly across Europe. These biobanks require robust and scalable biopreservation solutions to manage large volumes of biological materials while maintaining their quality over time. Furthermore, with the increasing trend of collaborative research between academic institutions, healthcare providers, and pharmaceutical companies, there is a heightened need for standardized and efficient biopreservation systems. The expansion of biobank networks and collaborations in Europe provides an opportunity for technology providers to supply advanced biopreservation solutions that can accommodate growing storage needs, streamline operations, and support innovative research in genomics, personalized medicine, and drug discovery.

Market Segmentation Analysis

By Type

The Europe Biopreservation Market is segmented by type into natural, microbial, and chemical preservatives. Natural preservatives, including plant extracts, enzymes, and organic acids, are gaining popularity due to their ability to preserve biological samples without synthetic chemicals, driven by a growing preference for safer, eco-friendly solutions. Microbial preservatives, such as bacteriocins and certain strains of bacteria, are essential for controlling pathogens and spoilage in biological samples, offering high efficacy and low cost, which makes them increasingly popular in healthcare and biotechnology. Chemical preservatives, like formaldehyde and glycerol, are still widely used, especially in cryopreservation, to protect cells and tissues during storage. However, the growing demand for natural and microbial alternatives may limit the growth of this segment, even though chemical preservatives remain crucial in high-demand applications such as pharmaceuticals and clinical research.

By Application

Biopreservation plays a crucial role across various industries, including food and beverages, pharmaceuticals, and cosmetics. In the food industry, biopreservation methods, such as natural and microbial preservatives, help maintain product quality, flavor, and nutritional content while extending shelf life, meeting growing consumer demand for natural, chemical-free options. In pharmaceuticals, biopreservation is essential for the storage of vaccines, biologics, and other sensitive materials, with cryopreservation techniques ensuring the integrity of these products. As biologics, personalized medicine, and regenerative therapies continue to grow, this segment is expected to expand significantly. In the cosmetics industry, biopreservation techniques prevent microbial contamination and help extend the shelf life of products, particularly those with organic or natural ingredients, responding to the rising demand for clean-label, sustainable options in Europe.

Segments

Based on Type

Natural Preservatives
Microbial Preservatives
Chemical Preservatives

Based on Application

Food and Beverages
Pharmaceuticals
Cosmetics

Based on Region

Western Europe
Northern Europe
Southern Europe
Eastern Europe

Regional Analysis

Western Europe (50%)

Western Europe holds the largest market share in the Europe Biopreservation Market, accounting for approximately 50% of the total market. Countries such as Germany, the UK, France, and Italy are the primary drivers of this regional market. These nations have well-established healthcare infrastructures, robust pharmaceutical and biotechnology industries, and extensive research and development activities, all of which significantly contribute to the demand for biopreservation solutions. The growing emphasis on regenerative medicine, personalized healthcare, and precision medicine further fuels the demand for biopreservation technologies in this region. Additionally, the presence of leading biopharmaceutical companies and research institutions in Western Europe creates substantial opportunities for biopreservation providers to deliver advanced solutions.

Northern Europe (20%)

Northern Europe, which includes countries such as Sweden, Denmark, Norway, and Finland, holds a market share of approximately 20%. This region is known for its strong emphasis on biotechnology research, medical innovations, and sustainability. The growth in the adoption of biopreservation solutions in Northern Europe is primarily driven by advancements in stem cell research, genomics, and regenerative medicine. The region’s focus on sustainability and eco-friendly solutions is also increasing the demand for natural and microbial preservatives in biopreservation processes. Furthermore, government investments in medical research and the expansion of biobank networks in countries like Sweden and Finland are boosting the demand for reliable preservation technologies.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

BASF SE
Hansen Holding A/S
Kemin Industries, Inc.
Thermo Fisher Scientific Inc.
DuPont de Nemours, Inc.
BioLife Solutions Inc.
Merck KGaA
Sigma-Aldrich (Merck Group)
SABIC
STEMCELL Technologies Inc.

Competitive Analysis

The Europe Biopreservation Market is highly competitive, with key players leveraging their strengths in research, product innovation, and strategic partnerships to maintain a strong market presence. Companies like Thermo Fisher Scientific, Merck KGaA, and BioLife Solutions are leaders, offering advanced biopreservation solutions, particularly in cryopreservation and storage systems, targeting the growing demand from the pharmaceutical, biotechnology, and research sectors. BASF SE and DuPont focus on natural and chemical preservatives, capitalizing on sustainability trends. While Merck and Sigma-Aldrich benefit from extensive portfolios and global reach, smaller companies like STEMCELL Technologies focus on niche markets, particularly in stem cell research, offering highly specialized biopreservation technologies. To stay competitive, companies are investing in R&D and expanding their product offerings, while also forming strategic collaborations to cater to the rising demand for biologics, personalized medicine, and regenerative therapies.

Recent Developments

In November 2024, BASF announced a partnership with Acies Bio to develop sustainable production methods for personal and home care ingredients using fermentation technology. This collaboration aims to leverage Acies Bio’s OneCarbonBio platform for efficient conversion of renewable methanol into chemical raw materials, enhancing BASF’s portfolio in sustainable biopreservation solutions.

In October 2024, Thermo Fisher launched a new line of biopreservation media designed for cell and gene therapy applications. This media is optimized to enhance cell viability and functionality during storage and transport, addressing the growing demand for reliable preservation methods in the biopharmaceutical sector.

In September 2024, Merck KGaA introduced a new range of cryopreservation solutions aimed at improving the long-term storage of biological samples. These solutions are tailored for use in research and clinical settings, ensuring higher recovery rates of viable cells post-thaw.

In August 2024, Kemin announced the expansion of its biopreservation product line with the launch of a new natural preservative derived from plant extracts. This product is designed to extend the shelf life of biological materials used in various applications, including food and pharmaceuticals.

In March 2024, STEMCELL Technologies released a new series of media formulations specifically designed for the preservation of hematopoietic stem cells. These formulations aim to improve recovery rates and functionality after thawing.

Market Concentration and Characteristics

The Europe Biopreservation Market is moderately concentrated, with a mix of global leaders and specialized players driving innovation and growth. Major players such as Thermo Fisher Scientific, Merck KGaA, and BioLife Solutions dominate the market, offering comprehensive product portfolios that cater to the pharmaceutical, biotechnology, and healthcare sectors. These companies benefit from strong R&D capabilities, extensive distribution networks, and strategic partnerships, enabling them to capture significant market share. However, the market also includes smaller, niche players like STEMCELL Technologies and Kemin Industries, which focus on specialized biopreservation solutions for areas such as stem cell research and personalized medicine. This combination of large-scale providers and niche innovators ensures a dynamic and competitive landscape. Additionally, the market is characterized by rapid technological advancements, increasing demand for sustainable solutions, and growing investments in the biotech and pharmaceutical industries, which continue to fuel market expansion and competition.

Report Coverage

The research report offers an in-depth analysis based on Type, Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The demand for advanced preservation methods like cryopreservation and vitrification will continue to rise, driven by advances in personalized medicine and regenerative therapies. These technologies are expected to gain broader acceptance across research and healthcare sectors in Europe.

As biobanks grow in number and size, the need for reliable and efficient biopreservation solutions will surge. Europe’s expanding biobank infrastructure will significantly drive market growth, particularly in genetic research and drug discovery.

Future advancements in cryopreservation, including more effective cryoprotectants and automated systems, will improve sample integrity and storage efficiency, enhancing the viability of stored biological materials.

The shift towards personalized medicine will increase the need for biopreservation technologies to store and transport genetic materials, blood samples, and tissues, creating substantial market opportunities.

Environmental concerns will drive the demand for sustainable biopreservation techniques. Companies will focus on eco-friendly preservatives and energy-efficient storage solutions to meet both regulatory standards and consumer preferences.

With Europe at the forefront of stem cell research, the need for biopreservation solutions to support long-term storage and transport of stem cells will continue to expand, further fueling market growth.

Government initiatives and increased funding for biotech and pharmaceutical research will foster innovation in biopreservation technologies, creating new growth opportunities for market players.

As consumers and companies seek safer, natural alternatives, the use of microbial and natural preservatives in biopreservation will rise, responding to the growing demand for clean-label and sustainable products.

Collaborative research efforts between pharmaceutical companies and academic institutions will increase the demand for biopreservation solutions to store and manage biological samples for clinical trials and other research purposes.

Emerging European countries, particularly in Eastern and Southern Europe, will see increased demand for biopreservation technologies due to investments in healthcare infrastructure and biotechnological research, expanding market reach beyond established regions.

CHAPTER NO. 1 : INTRODUCTION 18

1.1.1. Report Description 18

Purpose of the Report 18

USP & Key Offerings 18

1.1.2. Key Benefits for Stakeholders 18

1.1.3. Target Audience 19

1.1.4. Report Scope 19

CHAPTER NO. 2 : EXECUTIVE SUMMARY 20

2.1. Biopreservation Market Snapshot 20

2.1.1. Europe Biopreservation Market, 2018 – 2032 (USD Million) 21

CHAPTER NO. 3 : BIOPRESERVATION MARKET – INDUSTRY ANALYSIS 22

3.1. Introduction 22

3.2. Market Drivers 23

3.2.1. Increasing Demand for Natural and Organic Food Products 23

3.2.2. Stringent European Union Regulations on Food Safety 24

3.3. Market Restraints 25

3.3.1. High Research and Development Costs 25

3.4. Market Opportunities 26

3.4.1. Expanding Applications in Biomedical and Pharmaceutical Sectors 26

3.5. Porter’s Five Forces Analysis 27

3.6. Value Chain Analysis 28

3.7. Buying Criteria 29

CHAPTER NO. 4 : RAW MATERIALS ANALYSIS 30

4.1. Key Raw Materials and Suppliers 30

4.2. Key Raw Materials Price Trend 30

CHAPTER NO. 5 : MANUFACTURING COST ANALYSIS 31

5.1. Manufacturing Cost Analysis 31

5.2. Manufacturing Process 31

CHAPTER NO. 6 : ANALYSIS COMPETITIVE LANDSCAPE 32

6.1. Company Market Share Analysis – 2023 32

6.1.1. Europe Biopreservation Market: Company Market Share, by Volume, 2023 32

6.1.2. Europe Biopreservation Market: Company Market Share, by Revenue, 2023 33

6.1.3. Europe Biopreservation Market: Top 6 Company Market Share, by Revenue, 2023 33

6.1.4. Europe Biopreservation Market: Top 3 Company Market Share, by Revenue, 2023 34

6.2. Europe Biopreservation Market Company Volume Market Share, 2023 35

6.3. Europe Biopreservation Market Company Revenue Market Share, 2023 36

6.4. Company Assessment Metrics, 2023 36

6.4.1. Stars 36

6.4.2. Emerging Leaders 36

6.4.3. Pervasive Players 36

6.4.4. Participants 36

6.5. Start-ups /SMEs Assessment Metrics, 2023 36

6.5.1. Progressive Companies 36

6.5.2. Responsive Companies 36

6.5.3. Dynamic Companies 36

6.5.4. Starting Blocks 37

6.6. Strategic Developments 38

6.6.1. Acquisitions & Mergers 38

New Product Launch 38

Country Expansion 38

6.7. Key Players Product Matrix 39

CHAPTER NO. 7 : PESTEL & ADJACENT MARKET ANALYSIS 40

7.1. PESTEL 40

7.1.1. Political Factors 40

7.1.2. Economic Factors 40

7.1.3. Social Factors 40

7.1.4. Technological Factors 40

7.1.5. Environmental Factors 40

7.1.6. Legal Factors 40

7.2. Adjacent Market Analysis 40

CHAPTER NO. 8 : BIOPRESERVATION MARKET – BY TYPE SEGMENT ANALYSIS 41

8.1. Biopreservation Market Overview, by Type Segment 41

8.1.1. Biopreservation Market Revenue Share, By Type, 2023 & 2032 42

8.1.2. Biopreservation Market Attractiveness Analysis, By Type 43

8.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 43

8.1.4. Biopreservation Market Revenue, By Type, 2018, 2023, 2027 & 2032 44

8.2. Natural Preservatives 45

8.3. Microbial Preservatives 46

8.4. Chemical Preservatives 47

CHAPTER NO. 9 : BIOPRESERVATION MARKET – BY APPLICATION SEGMENT ANALYSIS 48

9.1. Biopreservation Market Overview, by Application Segment 48

9.1.1. Biopreservation Market Revenue Share, By Application, 2023 & 2032 49

9.1.2. Biopreservation Market Attractiveness Analysis, By Application 50

9.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 50

9.1.4. Biopreservation Market Revenue, By Application, 2018, 2023, 2027 & 2032 51

9.2. Food and Beverages 52

9.3. Pharmaceuticals 53

9.4. Cosmetics 54

CHAPTER NO. 10 : BIOPRESERVATION MARKET – EUROPE 55

10.1. Europe 55

10.1.1. Key Highlights 55

10.1.2. Europe Biopreservation Market Revenue, By Country, 2018 – 2023 (USD Million) 56

10.1.3. Europe Biopreservation Market Revenue, By Type, 2018 – 2023 (USD Million) 57

10.1.4. Europe Biopreservation Market Revenue, By Application, 2018 – 2023 (USD Million) 58

10.2. UK 59

10.3. France 59

10.4. Germany 59

10.5. Italy 59

10.6. Spain 59

10.7. Russia 59

10.8. Belgium 59

10.9. Netherland 59

10.10. Austria 59

10.11. Sweden 59

10.12. Poland 59

10.13. Denmark 59

10.14. Switzerland 59

10.15. Rest of Europe 59

CHAPTER NO. 11 : COMPANY PROFILES 60

11.1. BASF SE 60

11.1.1. Company Overview 60

11.1.2. Product Portfolio 60

11.1.3. Swot Analysis 60

11.1.4. Business Strategy 61

11.1.5. Financial Overview 61

11.2. Chr. Hansen Holding A/S 62

11.3. Kemin Industries, Inc. 62

11.4. Thermo Fisher Scientific Inc. 62

11.5. DuPont de Nemours, Inc. 62

11.6. BioLife Solutions Inc. 62

11.7. Merck KGaA 62

11.8. Sigma-Aldrich (Merck Group) 62

11.9. SABIC 62

11.10. STEMCELL Technologies Inc. 62

List of Figures

FIG NO. 1. Europe Biopreservation Market Revenue, 2018 – 2032 (USD Million) 21

FIG NO. 2. Porter’s Five Forces Analysis for Europe Biopreservation Market 27

FIG NO. 3. Value Chain Analysis for Europe Biopreservation Market 28

FIG NO. 4. Raw Materials Price Trend Analysis, 2018 – 2023 30

FIG NO. 5. Manufacturing Cost Analysis 31

FIG NO. 6. Manufacturing Process 31

FIG NO. 7. Company Share Analysis, 2023 32

FIG NO. 8. Company Share Analysis, 2023 33

FIG NO. 9. Company Share Analysis, 2023 33

FIG NO. 10. Company Share Analysis, 2023 34

FIG NO. 11. Biopreservation Market – Company Volume Market Share, 2023 35

FIG NO. 12. Biopreservation Market – Company Revenue Market Share, 2023 36

FIG NO. 13. Biopreservation Market Revenue Share, By Type, 2023 & 2032 42

FIG NO. 14. Market Attractiveness Analysis, By Type 43

FIG NO. 15. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 43

FIG NO. 16. Biopreservation Market Revenue, By Type, 2018, 2023, 2027 & 2032 44

FIG NO. 17. Europe Biopreservation Market for Natural Preservatives, Revenue (USD Million) 2018 – 2032 45

FIG NO. 18. Europe Biopreservation Market for Microbial Preservatives, Revenue (USD Million) 2018 – 2032 46

FIG NO. 19. Europe Biopreservation Market for Chemical Preservatives, Revenue (USD Million) 2018 – 2032 47

FIG NO. 20. Biopreservation Market Revenue Share, By Application, 2023 & 2032 49

FIG NO. 21. Market Attractiveness Analysis, By Application 50

FIG NO. 22. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 50

FIG NO. 23. Biopreservation Market Revenue, By Application, 2018, 2023, 2027 & 2032 51

FIG NO. 24. Europe Biopreservation Market for Food and Beverages, Revenue (USD Million) 2018 – 2032 52

FIG NO. 25. Europe Biopreservation Market for Pharmaceuticals, Revenue (USD Million) 2018 – 2032 53

FIG NO. 26. Europe Biopreservation Market for Cosmetics, Revenue (USD Million) 2018 – 2032 54

FIG NO. 27. Europe Biopreservation Market Revenue, 2018 – 2032 (USD Million) 55

List of Tables

TABLE NO. 1. : Europe Biopreservation Market: Snapshot 20

TABLE NO. 2. : Drivers for the Biopreservation Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the Biopreservation Market: Impact Analysis 25

TABLE NO. 4. : Key Raw Materials & Suppliers 30

TABLE NO. 5. : Europe Biopreservation Market Revenue, By Country, 2018 – 2023 (USD Million) 56

TABLE NO. 6. : Europe Biopreservation Market Revenue, By Country, 2024 – 2032 (USD Million) 56

TABLE NO. 7. : Europe Biopreservation Market Revenue, By Type, 2018 – 2023 (USD Million) 57

TABLE NO. 8. : Europe Biopreservation Market Revenue, By Type, 2024 – 2032 (USD Million) 57

TABLE NO. 9. : Europe Biopreservation Market Revenue, By Application, 2018 – 2023 (USD Million) 58

TABLE NO. 10. : Europe Biopreservation Market Revenue, By Application, 2024 – 2032 (USD Million) 58

Frequently Asked Questions

What is the market size of the Europe Biopreservation Market in 2023 and 2032?

The Europe Biopreservation Market is projected to reach USD 647.08 million in 2023 and grow to USD 5,783.90 million by 2032, with a CAGR of 23.95% from 2024 to 2032.

What are the key drivers of the Europe Biopreservation Market?

The market is driven by increasing demand for cell and tissue-based therapies, advancements in cryopreservation technologies, and the growing adoption of personalized medicine and clinical trials.

which industries benefit most from biopreservation techniques?

Healthcare, biobanking, pharmaceuticals, and personalized healthcare industries benefit the most, with applications in regenerative medicine, drug discovery, and tissue storage.

Which countries are major contributors to the Europe Biopreservation Market?

The UK, Germany, and France are significant contributors to the Europe Biopreservation Market, benefiting from robust healthcare systems and growing investments in biotechnology research.

What are the leading companies in the Europe Biopreservation Market?

Key players in the market include Thermo Fisher Scientific, BioLife Solutions, and Merck Group, which are known for their innovative biopreservation technologies and solutions.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –